Compare Stocks: HCAT, NRC, CTEV, and AMWL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMWL American Well	$12.21 -1.8%	$12.77	$3.71 ▼ $14.19	$205.74M	1.67	97,251 shs	62,232 shs
CTEV Claritev	$23.79 -2.2%	$31.94	$11.50 ▼ $73.68	$412.33M	0.93	184,940 shs	121,421 shs
HCAT Health Catalyst	$1.74 -0.6%	$1.74	$0.96 ▼ $3.62	$131.70M	1.54	416,015 shs	1.27 million shs
NRC National Research	$20.17 -1.2%	$21.06	$11.01 ▼ $23.68	$464.25M	0.25	120,102 shs	58,929 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMWL American Well	-2.07%	-2.53%	-4.73%	+13.25%	+113.49%
CTEV Claritev	-1.77%	-1.01%	-32.19%	-13.44%	-54.57%
HCAT Health Catalyst	-1.13%	-0.57%	+2.94%	-23.58%	-33.96%
NRC National Research	+0.39%	-1.78%	-3.36%	-7.14%	+77.79%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMWL American Well	$12.21 -1.8%	$12.77	$3.71 ▼ $14.19	$205.74M	1.67	97,251 shs	62,232 shs
CTEV Claritev	$23.79 -2.2%	$31.94	$11.50 ▼ $73.68	$412.33M	0.93	184,940 shs	121,421 shs
HCAT Health Catalyst	$1.74 -0.6%	$1.74	$0.96 ▼ $3.62	$131.70M	1.54	416,015 shs	1.27 million shs
NRC National Research	$20.17 -1.2%	$21.06	$11.01 ▼ $23.68	$464.25M	0.25	120,102 shs	58,929 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMWL American Well	-2.07%	-2.53%	-4.73%	+13.25%	+113.49%
CTEV Claritev	-1.77%	-1.01%	-32.19%	-13.44%	-54.57%
HCAT Health Catalyst	-1.13%	-0.57%	+2.94%	-23.58%	-33.96%
NRC National Research	+0.39%	-1.78%	-3.36%	-7.14%	+77.79%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMWL American Well	2.00	Hold	$9.50	-22.18% Downside
CTEV Claritev	2.56	Moderate Buy	$44.83	88.45% Upside
HCAT Health Catalyst	2.11	Hold	$2.15	23.56% Upside
NRC National Research	2.00	Hold	$26.00	28.90% Upside

Current Analyst Ratings Breakdown

Latest HCAT, NRC, CTEV, and AMWL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/9/2026	NRC National Research	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Hold (C-) ➝ Sell (D+)
10/5/2026	NRC National Research	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold
9/21/2026	CTEV Claritev	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
8/21/2026	NRC National Research	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (D+) ➝ Hold (C-)
8/20/2026	HCAT Health Catalyst	Canaccord Genuity Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy ➝ Hold	$3.00 ➝ $1.80
8/20/2026	CTEV Claritev	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Overweight	$28.00 ➝ $40.00
8/13/2026	AMWL American Well	Truist Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target	Hold	$7.50 ➝ $12.00
8/13/2026	CTEV Claritev	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Strong Sell ➝ Hold
8/13/2026	HCAT Health Catalyst	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Equal Weight	$1.75 ➝ $1.50
8/12/2026	CTEV Claritev	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Overweight	$73.00
8/12/2026	CTEV Claritev	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Equal Weight	$22.00 ➝ $30.00

(Data available from 10/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMWL American Well	$249.32M	0.81	N/A	N/A	$14.97 per share	0.82
CTEV Claritev	$965.41M	0.42	$14.87 per share	1.60	($10.10) per share	-2.36
HCAT Health Catalyst	$311.14M	0.42	$2.10 per share	0.83	$3.47 per share	0.50
NRC National Research	$137.39M	3.34	$1.25 per share	16.17	$0.62 per share	32.53

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMWL American Well	-$95.70M	-$4.77	N/A	N/A	N/A	-35.75%	-30.12%	-22.30%	11/3/2026 (Estimated)
CTEV Claritev	-$284.28M	-$17.01	N/A	N/A	N/A	-28.46%	N/A	-5.76%	N/A
HCAT Health Catalyst	-$177.97M	-$3.68	N/A	N/A	N/A	-90.61%	-1.83%	-0.80%	11/9/2026 (Estimated)
NRC National Research	$11.60M	$0.25	80.68	19.21	N/A	4.18%	164.26%	14.67%	10/26/2026 (Estimated)

Latest HCAT, NRC, CTEV, and AMWL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/9/2026	Q3 2026	HCAT Health Catalyst	-$0.02	N/A	N/A	N/A	$55.38 million	N/A
11/3/2026	Q3 2026	AMWL American Well	-$0.66	N/A	N/A	N/A	$47.29 million	N/A
10/26/2026	Q3 2026	NRC National Research	$0.21	N/A	N/A	N/A	$35.80 million	N/A
8/7/2026	Q2 2026	CTEV Claritev	-$4.10	$1.41	+$5.51	-$3.49	N/A	$257.48 million
8/6/2026	Q2 2026	HCAT Health Catalyst	$0.0299	$0.04	+$0.0101	-$0.55	$69.09 million	$70.49 million
8/4/2026	Q2 2026	AMWL American Well	-$0.86	-$0.59	+$0.27	-$0.59	$49.87 million	$52.05 million
7/28/2026	Q2 2026	NRC National Research	-$0.15	$0.31	+$0.46	-$0.15	$34.90 million	$35.39 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMWL American Well	N/A	N/A	N/A	N/A	N/A
CTEV Claritev	N/A	N/A	N/A	N/A	N/A
HCAT Health Catalyst	N/A	N/A	N/A	N/A	N/A
NRC National Research	$0.64	3.17%	+19.88%	256.00%	N/A

Latest HCAT, NRC, CTEV, and AMWL Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/15/2026	NRC National Research	quarterly	$0.16	3.27%	9/25/2026	9/25/2026	10/9/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMWL American Well	N/A	2.90	2.89
CTEV Claritev	N/A	1.00	1.00
HCAT Health Catalyst	1.51	2.70	2.70
NRC National Research	13.13	0.65	0.65

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMWL American Well	56.05%
CTEV Claritev	87.15%
HCAT Health Catalyst	85.00%
NRC National Research	47.26%

Insider Ownership

Company	Insider Ownership
AMWL American Well	12.84%
CTEV Claritev	7.40%
HCAT Health Catalyst	19.40%
NRC National Research	9.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMWL American Well	562	16.55 million	14.43 million	Optionable
CTEV Claritev	3,000	16.95 million	15.69 million	Optionable
HCAT Health Catalyst	1,200	75.26 million	60.66 million	Optionable
NRC National Research	357	22.75 million	20.65 million	Optionable

HCAT, NRC, CTEV, and AMWL Headlines

Recent News About These Companies

National Research (NASDAQ:NRC) Raised to "Hold" at Zacks Research

October 7, 2026 | americanbankingnews.com

National Research (NASDAQ:NRC) Stock Moved Up to "Hold" by Zacks Research

October 7, 2026 | marketbeat.com

What is Citizens Jmp's Estimate for NRC Q3 Earnings?

October 6, 2026 | americanbankingnews.com

What is Citizens Jmp's Forecast for NRC Q3 Earnings?

October 6, 2026 | marketbeat.com

National Research (NASDAQ:NRC) Stock Price Crosses Above 200 Day Moving Average - Here's What Happened

October 1, 2026 | marketbeat.com

Former U.S. NRC Commissioner and U.S. DOE Nuclear Chief William D. Magwood, IV to Join newcleo's Board of Directors in January 2027

September 30, 2026 | globenewswire.com

NRC Health Trades at a Discount: Should You Buy, Sell or Hold?

September 28, 2026 | zacks.com

National Research Corporation (NASDAQ:NRC) to Issue Quarterly Dividend of $0.16

September 23, 2026 | marketbeat.com

National Research (NASDAQ:NRC) Share Price Crosses Above Two Hundred Day Moving Average - What's Next?

September 17, 2026 | marketbeat.com

New Momentum in the Nuclear Fuel Chain

September 14, 2026 | etftrends.comE

Mercy Earns National Honor for Excellence in Patient Experience

September 1, 2026 | prnewswire.com

Report Shows National Academies Spending Drop as Trump Threatens Funding

August 19, 2026 | aip.orgA

Record Backlog Powers NRC Health’s (NRC) Upward Potential

August 10, 2026 | insidermonkey.com

NRC Down 8% Despite Q2 Earnings Rising Y/Y on TRCV Growth

August 3, 2026 | zacks.com

National Research: Q2 Earnings Snapshot

July 30, 2026 | finance.yahoo.com

National Research (NASDAQ:NRC) Draws Fresh Market Focus

July 30, 2026 | kalkinemedia.comK

NRC Health (NRC) Q2 2026 Earnings Call Transcript

July 29, 2026 | seekingalpha.com

NRC Health Announces Second Quarter 2026 Results

July 28, 2026 | businesswire.com

Nations Royalty Reports Fiscal 2026 Year-End Results and Provides Portfolio Update

July 28, 2026 | newsfilecorp.comN

MMF and NRC Agree to the Transfer of Property at 435-445 Ellice Avenue, Winnipeg

July 10, 2026 | ca.finance.yahoo.com

National Research Shareholders Approve Governance Reforms and Directors

June 29, 2026 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

HCAT, NRC, CTEV, and AMWL Company Descriptions

American Well NYSE:AMWL

$12.21 -0.22 (-1.79%)

Closing price 03:59 PM Eastern

Extended Trading

$12.50 +0.29 (+2.35%)

As of 07:30 PM Eastern

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Claritev NYSE:CTEV

$23.79 -0.54 (-2.22%)

As of 03:58 PM Eastern

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.

Health Catalyst NASDAQ:HCAT

$1.74 -0.01 (-0.57%)

Closing price 04:00 PM Eastern

Extended Trading

$1.73 -0.01 (-0.57%)

As of 06:20 PM Eastern

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

National Research NASDAQ:NRC

$20.17 -0.24 (-1.18%)

Closing price 04:00 PM Eastern

Extended Trading

$20.18 +0.00 (+0.02%)

As of 04:01 PM Eastern

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HCAT, NRC, CTEV, and AMWL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HCAT, NRC, CTEV, and AMWL Earnings

Compare Dividends

Latest HCAT, NRC, CTEV, and AMWL Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HCAT, NRC, CTEV, and AMWL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

HCAT, NRC, CTEV, and AMWL Company Descriptions

American Well NYSE:AMWL

Claritev NYSE:CTEV

Health Catalyst NASDAQ:HCAT

National Research NASDAQ:NRC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools